• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

LY2140023

Triple-negative breast cancer (TNBC) is definitely a heterogeneous disease; gene manifestation

December 20, 2018 by Katherine Lewis Leave a Comment

Triple-negative breast cancer (TNBC) is definitely a heterogeneous disease; gene manifestation (GE) analyses lately identified six specific TNBC subtypes, each showing a distinctive biology. faraway recurrence and loss of life compared with ladies with other styles of breasts cancer (3), and a tendency to build up visceral metastases early throughout their disease. Improved methods to … [Read more…]

Posted in: Blogging Tagged: LY2140023, Rabbit Polyclonal to MARK4

Microsporidia are currently considered emerging pathogens responsible for life-threatening infections in

May 10, 2017 by Katherine Lewis Leave a Comment

Microsporidia are currently considered emerging pathogens responsible for life-threatening infections in organ transplant recipients. diagnosis of other syndromes such as chronic fever of unknown etiology. INTRODUCTION Microsporidia are ubiquitous obligate intracellular opportunistic parasites recently related to fungi capable of infecting a wide range of vertebrate and invertebrate hosts (2 12 Within microsporidia 8 genera and … [Read more…]

Posted in: EDG Receptors Tagged: LY2140023, Rabbit Polyclonal to MARCH3.

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by